Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics. - Wikidata - awgldk - TriplyDB

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

http://www.wikidata.org/entity/Q34359268

about

Stem cells as cellular vehicles for gene therapy against glioblastoma Gene therapy for brain tumors: basic developments and clinical implementation Insights into cytokine-receptor interactions from cytokine engineering Identification of novel tumor-associated cell surface sialoglycoproteins in human glioblastoma tumors using quantitative proteomics Challenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer.Adenoviral vector-mediated gene therapy for gliomas: coming of age.Interleukin-13 receptor alpha 2-targeted glioblastoma immunotherapy.Evidence of oligodendrogliosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism.Current status of gene therapy for brain tumors.Engineering toxin-resistant therapeutic stem cells to treat brain tumors Intracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer.New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors.Gene therapy for the nervous system: challenges and new strategies.IL-13Rα2-Targeted Therapy Escapees: Biologic and Therapeutic Implications.Targeted toxins for glioblastoma multiforme: pre-clinical studies and clinical implementation.New therapeutic approaches for malignant glioma: in search of the Rosetta stone Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model The art of gene therapy for glioma: a review of the challenging road to the bedside Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic Improved Adeno-associated Viral Gene Transfer to Murine Glioma.Strategies in gene therapy for glioblastoma.Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.Genetic therapy for the nervous system.Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy.Emerging insights into barriers to effective brain tumor therapeutics.IL13RA2 targeted alpha particle therapy against glioblastomas.Sustained production of a soluble IGF-I receptor by gutless adenovirus-transduced host cells protects from tumor growth in the liver.A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarker.LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors.Maximizing gene delivery efficiencies of cationic helical polypeptides via balanced membrane penetration and cellular targeting.The effect of side-chain functionality and hydrophobicity on the gene delivery capabilities of cationic helical polypeptides.Trigger-responsive, fast-degradable poly(β-amino ester)s for enhanced DNA unpackaging and reduced toxicity.Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges.From the bench to the bedside: Everolimus for subependymal giant cell astrocytomas in Tuberous sclerosis complex, optic nerve regeneration, targeted cytotoxins for gliomas Non-viral gene delivery via membrane-penetrating, mannose-targeting supramolecular self-assembled nanocomplexes.Gene Delivery Method Using Photo-Responsive Poly(β-Amino Ester) as Vectors.Reconfiguring the architectures of cationic helical polypeptides to control non-viral gene delivery.Gene therapy and targeted toxins for glioma

P2860

Q26771835-82454479-3FEE-4B70-83C4-B7139CA919A0 Q26829086-AF8C534E-43D6-47B2-9245-61263794059C Q26852703-7D1C060E-F43F-4717-B894-7167669432DB Q28544645-5BA1F7DC-85D3-405E-8FC0-9A2E44CD7728 Q33864348-E59BC93D-CBD7-433E-A847-5D6423147584 Q34022048-24690AD8-EB81-41DE-9CC2-B042671178D8 Q34177641-9FA62A03-995E-42B2-9E18-D14CF6D1B2DB Q34207470-B13C304A-7A97-47D7-ADF6-98D96D24A9D8 Q34318157-E30ACD3B-6962-4313-B23A-E46ABE5FEFAB Q34444939-21A82E57-537C-41B4-A538-F66CE142D5B7 Q34751465-EA8D3EAC-1BC9-4181-B02A-268EA238A9D4 Q35023359-CD7EF437-2AB3-43DC-A163-B07A4FB1361A Q35340196-DE001947-D8A5-4AE0-9D13-C060515F45C2 Q35626536-0AD61C96-4599-4DDE-9FF8-343C24564252 Q35999648-1150279C-CD8A-457B-8DC1-DCA57F1CA386 Q36224493-190E1D25-693D-4E02-A5CB-57BAC03B312C Q36345439-197CC553-355A-4819-910C-924FDC2C6899 Q36527593-4ACA3191-8532-4CE4-BD2A-D31A4531C63B Q36755625-F4E43C61-EC01-4034-B6C0-4B0E1095BBEB Q37366610-DD5E6593-F68E-4545-BD92-3501CC62D724 Q37420576-C418D7C3-4A21-46FC-8302-FA277F52D6FA Q37804933-23E18EFB-B6D5-41A9-A0A8-84E996FA41DB Q37856565-1F58282C-DC7B-438A-9165-468E760CE56E Q38203856-65BFC4F7-A8A4-4C05-B50B-B6F80C130286 Q38237653-A115CFD4-7B34-4426-AA1E-A1A4AF2DA764 Q38754116-D5BAE876-BD84-4F85-9891-B7731F59535C Q39183606-56531685-EECE-4915-A78E-8C8849078FBD Q39284797-61282620-1854-4666-8095-46747067F9A0 Q39354544-8426BC64-3F83-45B6-BFC9-D6E9AA61826F Q39462845-B56C4621-64A1-4D5A-B55C-C49964DA2043 Q40892791-CEF0FCC4-6425-4CA4-A2C6-F2586B9EF53A Q40892983-F0DBEA48-3F3E-410C-A597-B29F54AC6B5E Q40893124-A91DAE09-61EF-4E9D-AE79-8D592FA3A552 Q41022992-6AA9302F-36CB-4CEC-8F22-8D97EB9B14B1 Q41813026-D9C13A08-79F8-4239-A165-35EC73B53459 Q41899969-657B327B-9C19-4D65-AFE3-03AAB6CB9313 Q50223673-FD2C771C-8F65-4C1E-B1D6-249F7B16D479 Q55054389-A038F1E6-85E6-4026-85C7-8170C6E76F3A Q57006162-F9FB6CAF-B0A2-4E4F-8255-2E23E2E564F3

P2860

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

http://www.wikidata.org/entity/Q34359268

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

@ast

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

@en

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

@nl

type

label

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

@ast

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

@en

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

@nl

prefLabel

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

@ast

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

@en

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

@nl

P1433

Q34359268-24C55921-0C3A-44FB-9A90-9A22F3B15B50

P1476

Q34359268-78EAFB37-1AB7-4676-B100-D8E9580D44BE

P2093

Q34359268-03150CA3-6966-4C6E-B131-7B710DAF718B

Q34359268-17C66BAA-8420-49A3-9900-516818797F76

Q34359268-1F7A9CCF-D804-42C0-A55A-324F99210600

Q34359268-2B552D2A-AAC9-4218-8888-69E4AB537F71

Q34359268-32473953-449C-45A1-A935-C7DA0BC3F051

Q34359268-35C38E08-DE33-4356-A2B0-CC1371FFD6B5

Q34359268-4C784301-E101-4D83-B2E7-263D3AB7FB9F

Q34359268-4EC6801F-AE0A-463F-B9B9-0FB3BED4A774

Q34359268-502FE850-E241-46D8-8CF4-A113583554EC

Q34359268-873015F0-34FA-43B6-8C13-66AEAB24BBB7

P2860

Q34359268-038A39F4-907D-4214-9112-AC736EEAA1BC

Q34359268-21E24C13-ADE0-4880-A3EA-0607B8C1C186

Q34359268-2CC7DE96-22CD-4015-BDF5-C4E44E8CAED5

Q34359268-3363244A-5537-4FC0-A028-791BA0642CD5

Q34359268-370FAD3F-D9B1-40BC-B2BC-5E4860B5C879

Q34359268-464E56FE-660D-4444-9148-0FA0C5B79E07

Q34359268-4F2D011B-7FC3-444D-B00F-5029E170B9F5

Q34359268-566DAD2C-E053-445D-9728-F7E54F4DF210

Q34359268-5C67E9FB-6819-4AC3-8418-A8548554D29C

Q34359268-6081D413-8CEB-4504-9942-FC799DDACD2E

P304

Q34359268-EC3F78BD-0CCD-46EF-8C40-AAC9E1D413FF

P31

Q34359268-C399D548-A542-416F-BC1F-A0D5FF2EA456

P356

Q34359268-96ECB28F-5C68-4351-AC0E-D61A47689271

P407

Q34359268-2B161B20-E516-4C82-A15F-43B0C8BE7716

P433

Q34359268-627931AA-6B1A-4944-AE30-A0BBF73E0DBD

P478

Q34359268-E5074049-3102-4609-9DD9-864AAD75ADAF

P50

Q34359268-F51ED610-3AA2-4796-9952-88A8B24AE5C5

P577

Q34359268-DF4E0D19-7556-4138-9E8C-8F2022856019

P5875

Q34359268-277B7FB7-E9EE-436B-A43A-D692BFAFFD6A

P698

Q34359268-ED443850-6CEB-4AF4-9A75-950CF37AD28F

P921

Q34359268-C730AD8C-EA11-4892-AD2E-D98673F9EEAC

P932

Q34359268-C934CC0B-142D-416A-A450-BC13A7E530AA

P356

PNAS.1008261107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics

@en

P2093

A K M G Muhammad

http://www.w3.org/2001/XMLSchema#string

Ali Zadmehr

http://www.w3.org/2001/XMLSchema#string

Chunyan Liu

http://www.w3.org/2001/XMLSchema#string

Clive N Svendsen

http://www.w3.org/2001/XMLSchema#string

David Foulad

http://www.w3.org/2001/XMLSchema#string

Dhruv Sareen

http://www.w3.org/2001/XMLSchema#string

Gabrielle E Ahlzadeh

http://www.w3.org/2001/XMLSchema#string

Kader Yagiz

http://www.w3.org/2001/XMLSchema#string

Kurt M Kroeger

http://www.w3.org/2001/XMLSchema#string

Mariana Puntel

http://www.w3.org/2001/XMLSchema#string

P2860

HMGB1 mediates endogenous TLR2 activation and brain tumor regression

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses.

IL-13 receptors and signaling pathways: an evolving web.

Design and application of oncolytic HSV vectors for glioblastoma therapy.

Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression.

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.

Targeted therapies for malignant glioma: progress and potential.

Immunization against the transgene but not the TetON switch reduces expression from gutless adenoviral vectors in the brain.

Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity.

P304

20021-20026

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1008261107

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47621680

http://www.w3.org/2001/XMLSchema#string

P698

21030678

http://www.w3.org/2001/XMLSchema#string

P921

P932

2993419

http://www.w3.org/2001/XMLSchema#string